KANSAS CITY, Kan., April 09, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (CING) (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...
Americans' use of anti-anxiety medications has increased dramatically, and while medications can play an important role in the treatment of anxiety disorders, they are not risk-free and in some cases ...
Cingulate Inc. completes FDA Pre-NDA meeting for ADHD drug CTx-1301 and secures $3 million grant for anxiety treatment CTx-2103. Cingulate Inc. announced the successful completion of a Pre-NDA meeting ...
Pharmaceutical Technology on MSN
Cingulate secures $3m to advance once-daily anxiety treatment
US biopharmaceutical company Cingulate has announced the receipt of a $3m grant from a private foundation to expedite the development of a once-daily formulation of buspirone, CTx-2103, to treat ...
Beta-Blockers for Anxiety: What Are They? Beta-blockers are medications that slow down certain types of cell activity in your body. Doctors often prescribe them to treat heart and circulatory problems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback